Alpa Laboratories Limited Share Price & Analysis
₹67.98▲ +0.95%Updated 5 May 2026, 11:31 am IST
LTP
₹67.98
+0.95%
Open
₹—
High
₹68.68
Low
₹66.25
Close
₹67.98
52W High
₹120
52W Low
₹46
Volume
3K
Lot Size
1
Sector
Healthcare
Market Cap
₹139 Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
11.9
Sector P/E
39.9
P/B
0.78
EPS
₹5.53
ROE
12.1%
ROCE
15.8%
D/E Ratio
0
Div Yield
0%
Book Value
₹87.1
+
Strengths
- ✓Efficient capital deployment (ROCE 15.8%)
- ✓Attractively valued vs sector (P/E 11.9x vs industry 39.9x)
- ✓Trading below book value (P/B 0.8x)
- ✓Virtually debt-free
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,830 | ₹4.3L Cr | 35.8 | 5.65 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,641 | ₹1.7L Cr | 68.1 | 11.43 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,308 | ₹1.4L Cr | 61.4 | 17.23 | 26.5 | 27 | 0.33 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,281 | ₹1.1L Cr | 19.8 | 2.97 | 18 | 22.7 | 0.16 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹7,767 | ₹1.1L Cr | 60.5 | 12.29 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,336 | ₹1.1L Cr | 22.2 | 3.28 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,380 | ₹1.1L Cr | 21.2 | 5.54 | 20.6 | 21.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ALPA · as of Mar 2026
Promoters57.29%
FII0.40%▲0.05
Public42.30%▼0.04
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% |
| FII | 0.95% | 0.50% | 0.36% | 0.74% | 0.35% | 0.40% |
| Public | 41.74% | 42.21% | 42.35% | 41.97% | 42.34% | 42.30% |
Corporate Events
Annual General Meeting
AGM19 Sept 2024
Annual General Meeting
AGM20 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹29.05 Cr ▲10.6% | ₹26.26 Cr ▲37.4% | ₹19.11 Cr ▼52.1% | ₹39.92 Cr ▲52.7% | ₹26.15 Cr ▲4.9% | ₹24.94 Cr ▲16.3% | ₹21.44 Cr ▼9.2% | ₹23.61 Cr |
| Op. Profit | ₹1.51 Cr ▲167.1% | ₹-2.25 Cr ▼623.3% | ₹0.43 Cr ▲115.0% | ₹0.2 Cr ▼73.0% | ₹0.74 Cr ▼77.7% | ₹3.32 Cr ▲526.4% | ₹0.53 Cr ▼84.9% | ₹3.51 Cr |
| OPM | 5.2% ▲160.7% | -8.6% ▼480.9% | 2.3% ▲350.0% | 0.5% ▼82.3% | 2.8% ▼78.7% | 13.3% ▲438.9% | 2.5% ▼83.4% | 14.9% |
| Net Profit | ₹1.9 Cr ▲1627.3% | ₹0.11 Cr ▼99.1% | ₹11.77 Cr ▲655.2% | ₹-2.12 Cr ▼123.8% | ₹8.9 Cr ▲15.7% | ₹7.69 Cr ▲50.8% | ₹5.1 Cr ▲43.7% | ₹3.55 Cr |
| EPS (₹) | 0.9 ▲1700.0% | 0.05 ▼99.1% | 5.59 ▲653.5% | -1.01 ▼123.9% | 4.23 ▲15.9% | 3.65 ▲50.8% | 2.42 ▲43.2% | 1.69 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹110 Cr ▲0.9% | ₹109 Cr ▲17.2% | ₹93 Cr ▼17.0% | ₹112 Cr ▲15.5% | ₹97 Cr ▲14.1% | ₹85 Cr ▲10.4% | ₹77 Cr ▲24.2% | ₹62 Cr ▼1.6% | ₹63 Cr |
| Expenses | ₹105 Cr ▲5.0% | ₹100 Cr ▲17.6% | ₹85 Cr ▼15.8% | ₹101 Cr ▲12.2% | ₹90 Cr ▲12.5% | ₹80 Cr ▲5.3% | ₹76 Cr ▲31.0% | ₹58 Cr ▲3.6% | ₹56 Cr |
| Op. Profit | ₹5 Cr ▼44.4% | ₹9 Cr ▲12.5% | ₹8 Cr ▼27.3% | ₹11 Cr ▲37.5% | ₹8 Cr ▲33.3% | ₹6 Cr ▲500.0% | ₹1 Cr ▼75.0% | ₹4 Cr ▼42.9% | ₹7 Cr |
| OPM | 4.0% ▼50.0% | 8.0% ▼11.1% | 9.0% ▼10.0% | 10.0% ▲25.0% | 8.0% ▲14.3% | 7.0% ▲600.0% | 1.0% ▼85.7% | 7.0% ▼36.4% | 11.0% |
| Other Income | ₹23 Cr ▲64.3% | ₹14 Cr ▲55.6% | ₹9 Cr ▼18.2% | ₹11 Cr ▲175.0% | ₹4 Cr | ₹0 Cr ▼100.0% | ₹5 Cr ▲0.0% | ₹5 Cr ▲66.7% | ₹3 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼50.0% | ₹2 Cr |
| Depreciation | ₹2 Cr ▲0.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼66.7% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr |
| PBT | ₹26 Cr ▲23.8% | ₹21 Cr ▲31.3% | ₹16 Cr ▼20.0% | ₹20 Cr ▲81.8% | ₹11 Cr ▲266.7% | ₹3 Cr ▲0.0% | ₹3 Cr ▼40.0% | ₹5 Cr ▼16.7% | ₹6 Cr |
| Tax % | 24.0% ▲26.3% | 19.0% ▼9.5% | 21.0% ▼25.0% | 28.0% ▼15.2% | 33.0% ▼8.3% | 36.0% ▼42.9% | 63.0% ▲61.5% | 39.0% ▼29.1% | 55.0% |
| Net Profit | ₹20 Cr ▲17.6% | ₹17 Cr ▲30.8% | ₹13 Cr ▼7.1% | ₹14 Cr ▲100.0% | ₹7 Cr ▲250.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼66.7% | ₹3 Cr ▲0.0% | ₹3 Cr |
| EPS (₹) | 9.27 ▲16.2% | 7.98 ▲33.4% | 5.98 ▼10.7% | 6.7 ▲94.2% | 3.45 ▲292.0% | 0.88 ▲83.3% | 0.48 ▼64.2% | 1.34 ▲11.7% | 1.2 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr ▲0.0% | ₹21 Cr |
| Reserves | ₹162 Cr ▲8.0% | ₹150 Cr ▲14.5% | ₹131 Cr ▲14.9% | ₹114 Cr ▲12.9% | ₹101 Cr ▲16.1% | ₹87 Cr ▲10.1% | ₹79 Cr ▲2.6% | ₹77 Cr ▲0.0% | ₹77 Cr ▲4.1% | ₹74 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr ▼100.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▼66.7% | ₹6 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr ▼66.7% | ₹6 Cr ▼45.5% | ₹11 Cr |
| Other Liabilities | ₹54 Cr ▲5.9% | ₹51 Cr ▲104.0% | ₹25 Cr ▼16.7% | ₹30 Cr ▲7.1% | ₹28 Cr ▼15.2% | ₹33 Cr ▲57.1% | ₹21 Cr ▲0.0% | ₹21 Cr ▲16.7% | ₹18 Cr ▼10.0% | ₹20 Cr |
| Total Liabilities | ₹238 Cr ▲6.7% | ₹223 Cr ▲22.5% | ₹182 Cr ▲9.0% | ₹167 Cr ▲7.7% | ₹155 Cr ▲10.7% | ₹140 Cr ▲15.7% | ₹121 Cr ▲0.0% | ₹121 Cr ▼0.8% | ₹122 Cr ▼3.2% | ₹126 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹21 Cr ▲0.0% | ₹21 Cr ▲90.9% | ₹11 Cr ▲57.1% | ₹7 Cr ▼22.2% | ₹9 Cr ▲28.6% | ₹7 Cr ▲16.7% | ₹6 Cr ▼25.0% | ₹8 Cr ▼20.0% | ₹10 Cr ▼33.3% | ₹15 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr ▲100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹145 Cr ▲22.9% | ₹118 Cr ▲20.4% | ₹98 Cr ▲25.6% | ₹78 Cr ▲4.0% | ₹75 Cr ▲47.1% | ₹51 Cr ▼10.5% | ₹57 Cr ▲16.3% | ₹49 Cr ▲58.1% | ₹31 Cr ▲138.5% | ₹13 Cr |
| Other Assets | ₹71 Cr ▼15.5% | ₹84 Cr ▲15.1% | ₹73 Cr ▼11.0% | ₹82 Cr ▲15.5% | ₹71 Cr ▼12.3% | ₹81 Cr ▲39.7% | ₹58 Cr ▼10.8% | ₹65 Cr ▼19.8% | ₹81 Cr ▼16.5% | ₹97 Cr |
| Total Assets | ₹238 Cr ▲6.7% | ₹223 Cr ▲22.5% | ₹182 Cr ▲9.0% | ₹167 Cr ▲7.7% | ₹155 Cr ▲10.7% | ₹140 Cr ▲15.7% | ₹121 Cr ▲0.0% | ₹121 Cr ▼0.8% | ₹122 Cr ▼3.2% | ₹126 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹18 Cr ▲350.0% | ₹4 Cr ▼55.6% | ₹9 Cr ▼10.0% | ₹10 Cr ▲600.0% | ₹-2 Cr ▼111.1% | ₹18 Cr ▲1900.0% | ₹-1 Cr ▲92.3% | ₹-13 Cr ▼176.5% | ₹17 Cr ▲177.3% | ₹-22 Cr |
| Investing CF | ₹-12 Cr ▲7.7% | ₹-13 Cr ▼750.0% | ₹2 Cr ▲112.5% | ₹-16 Cr ▼366.7% | ₹6 Cr ▲154.5% | ₹-11 Cr ▲26.7% | ₹-15 Cr ▼36.4% | ₹-11 Cr ▼450.0% | ₹-2 Cr ▲75.0% | ₹-8 Cr |
| Financing CF | ₹-5 Cr ▼266.7% | ₹3 Cr ▲175.0% | ₹-4 Cr ▼180.0% | ₹5 Cr | ₹0 Cr ▲100.0% | ₹-1 Cr ▲80.0% | ₹-5 Cr ▼155.6% | ₹9 Cr ▲160.0% | ₹-15 Cr ▼150.0% | ₹-6 Cr |
| Net Cash Flow | ₹1 Cr ▲114.3% | ₹-7 Cr ▼200.0% | ₹7 Cr | ₹0 Cr ▼100.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▲125.0% | ₹-20 Cr ▼33.3% | ₹-15 Cr | ₹0 Cr ▲100.0% | ₹-36 Cr |
| Free Cash Flow | ₹7 Cr ▲333.3% | ₹-3 Cr ▼137.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▲260.0% | ₹-5 Cr ▼133.3% | ₹15 Cr ▲850.0% | ₹-2 Cr ▲86.7% | ₹-15 Cr ▼193.8% | ₹16 Cr ▲150.0% | ₹-32 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 155d ▲12.3% | 138d ▼25.0% | 184d ▲48.4% | 124d ▼6.8% | 133d ▲26.7% | 105d ▼26.1% | 142d ▼7.2% | 153d ▼8.9% | 168d ▼28.2% | 234d |
| Inventory Days | 92d ▲26.0% | 73d ▼13.1% | 84d ▲3.7% | 81d ▼20.6% | 102d ▲13.3% | 90d ▼14.3% | 105d ▼23.9% | 138d ▲5.3% | 131d ▼33.2% | 196d |
| Days Payable | 97d ▲54.0% | 63d ▼37.0% | 100d ▲28.2% | 78d ▼48.7% | 152d ▲55.1% | 98d ▼1.0% | 99d ▼26.1% | 134d ▼4.3% | 140d ▼42.6% | 244d |
| Cash Conv. Cycle | 150d ▲0.7% | 149d ▼11.3% | 168d ▲32.3% | 127d ▲53.0% | 83d ▼14.4% | 97d ▼34.9% | 149d ▼5.1% | 157d ▼1.3% | 159d ▼15.0% | 187d |
| Working Capital Days | 110d ▼18.5% | 135d ▼11.2% | 152d ▲28.8% | 118d ▼15.7% | 140d ▲12.0% | 125d ▼35.6% | 194d ▼6.7% | 208d ▲19.5% | 174d ▼14.7% | 204d |
| ROCE | 16.0% ▲6.7% | 15.0% ▲25.0% | 12.0% ▲33.3% | 9.0% ▲28.6% | 7.0% ▲40.0% | 5.0% ▲66.7% | 3.0% ▼50.0% | 6.0% ▼25.0% | 8.0% ▼20.0% | 10.0% |
Source: Screener.in · Lower days = better efficiency
About Alpa Laboratories Limited
Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Alpa Laboratories Limited share price today?▾
Alpa Laboratories Limited (ALPA) is currently trading at ₹67.98 on NSE, up 0.95% as of the last market session. Prices update daily after market close on MarketNetra.
Is Alpa Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Alpa Laboratories Limited (ALPA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Alpa Laboratories Limited 52-week high and low?▾
Alpa Laboratories Limited's 52-week high is ₹120 and the 52-week low is ₹46. The current price of ₹67.98 is 43.3% below the 52W high.
What is Alpa Laboratories Limited P/E ratio?▾
Alpa Laboratories Limited's current P/E ratio is 11.9. This indicates the market is paying ₹11.9 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Alpa Laboratories Limited options?▾
Alpa Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ALPA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.